cagrilintide approval fda Novo Nordisk Submits CagriSema for FDA for Obesity Treatment Semaglutide, a glucagon-like peptide-1 (GLP-1)

Researchers reference them in the same sentence, cite each others data across both compounds, and occasionally order one when they mean to study the other

These results are often better than what people see with diet and exercise alone or some other medications

Cagrilintide is currently available through research peptide suppliers for investigational use only

The logic is real but indirect: NAD+ falls with age, sirtuins depend on it, and propping up NAD+ is a recurring theme across the longevity peptides and compounds people study

van der Voort R, Taher TE, Wielenga VJ, Spaargaren M, Prevo R, Smit L, David G, Hartmann G, Gherardi E, Pals ST

HC El Greco: Jos Enrique Mario Surez, Jos Luis Quintana Gmez, Jos Antonio Gonzlez-Posada Delgado, Enrique Revilla Pascual, Esperanza Duralde Rodrguez, Milagros Beamud Lagos